Myf-6 Polyclonal Antibody

Myogenic factor 6 encoded by MYF6 is a probable basic helix-loop-helix (bHLH) DNA binding protein involved in muscle differentiation. The encoded protein likely acts as a heterodimer with another bHLH protein. Defects in this gene are a cause of autosomal dominant centronuclear myopathy (ADCNM). Diseases associated with MYF6 include myopathy, centronuclear, 3 and myopathy, centronuclear. Among its related pathways are Developmental Biology and CDO in myogenesis. Gene Ontology (GO) annotations related to this gene include transcription factor activity, sequence-specific DNA binding and RNA polymerase II core promoter proximal region sequence-specific DNA binding. An important paralog of this gene is MYOD1.

The Myf-6 Polyclonal Antibody is a highly specific and reliable tool for the detection and analysis of Myf-6 protein expression. This antibody has been extensively validated for use in various applications, including Western blotting, immunohistochemistry, and immunofluorescence.

The Myf-6 Polyclonal Antibody exhibits exceptional sensitivity and specificity, ensuring accurate and reproducible results. It recognizes the Myf-6 protein with high affinity, enabling the detection of even low levels of expression.

This antibody is produced using state-of-the-art techniques, ensuring batch-to-batch consistency and high purity. It has been rigorously tested to ensure minimal cross-reactivity with other proteins, guaranteeing reliable and specific detection of Myf-6.

The Myf-6 Polyclonal Antibody is supplied in a convenient and ready-to-use format, allowing for easy integration into your experimental workflow. It is provided in a liquid formulation, eliminating the need for reconstitution and minimizing the risk of sample contamination.

With its exceptional performance and reliability, the Myf-6 Polyclonal Antibody is an indispensable tool for researchers studying Myf-6 protein expression and its role in various biological processes.